How to correlate plant performance to business performance
In theory, well-running manufacturing plants should mean more successful business enterprises, but quantifying that relationship, and actually correlating operational and business performance, are not easily done. To address this question, MESA International (Chandler, AZ), together with a business-IT consulting firm, Cambashi (Cummaquid, MA) have sponsored an opt-in survey that wound up during September. Preliminary results will be unveiled at the MESA Europe Plant-to-Enterprise Conference (Utrecht, the Netherlands, Oct. 27-28), and then a final report issued in January. Respondents have an incentive to join in the survey; non-MESA members have a chance to win a free membership in the industry organization.
The survey asks questions about types of software (such as manufacturing execution systems, or MESs, and enterprise systems), and then performance measurements relative to product life cycle, quality, regulatory compliance and supply chain management.
“MESA is concerned with how performance KPIs translate to continuous improvement and how production impacts the company’s success. Most industrial companies have a huge challenge to transform KPIs into actionable intelligence that improves business performance, and with this study, we aim to deliver not only data, but insights into good practices, and how to get a return on plant investments,” according to MESA Metrics Working Group co-Chairman Steven Kaplan of Murata Power Solutions.
Sponsors of the study include MES vendors GE Fanuc Intelligent Platforms, Rockwell Automation, Invensys Operations Management and Siemens; a “supporting” sponsor is SAP
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.